Decreased Expression of 15-hydroxyprostaglandin Dehydrogenase in Gastric Carcinomas
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Gastric carcinoma tissues release high level of prostaglandin E2 (PGE2) when compared to non-neoplastic mucosa, and cyclooxygenase-2 (COX-2), which is the rate-limiting enzyme in prostaglandin (PG) biosynthesis, is often overexpressed in gastric carcinomas and during gastric carcinogenesis. However, little is known about the expression of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), the key enzyme responsible for the biological inactivation of PG, in gastric carcinomas. Materials and Methods: We investigated the expression of 15-PGDH in 28 cases of advanced gastric carcinomas by Western blot analysis and also the relation between its expression and the gene promoter methylation. Results: 15-PGDH expression was significantly decreased in gastric carcinomas compared to corresponding non-neoplastic tissues and inversely correlated with the expression of proliferating cell nuclear antigen in gastric carcinomas. However, there was no correlation between 15-PGDH expression and pathological findings such as nodal metastasis and vascular invasion. Promoter hypermethylation of 15-PGDH gene was not detected in carcinomas, with only a negligible expression of the enzyme. Conclusion: Our results suggested that 15- PGDH has tumor suppressor activity in gastric carcinomas.
Abstract
Purpose: Gastric carcinoma tissues release high level of prostaglandin E2 (PGE2) when compared to non-neoplastic mucosa, and cyclooxygenase-2 (COX-2), which is the rate-limiting enzyme in prostaglandin (PG) biosynthesis, is often overexpressed in gastric carcinomas and during gastric carcinogenesis. However, little is known about the expression of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), the key enzyme responsible for the biological inactivation of PG, in gastric carcinomas. Materials and Methods: We investigated the expression of 15-PGDH in 28 cases of advanced gastric carcinomas by Western blot analysis and also the relation between its expression and the gene promoter methylation. Results: 15-PGDH expression was significantly decreased in gastric carcinomas compared to corresponding non-neoplastic tissues and inversely correlated with the expression of proliferating cell nuclear antigen in gastric carcinomas. However, there was no correlation between 15-PGDH expression and pathological findings such as nodal metastasis and vascular invasion. Promoter hypermethylation of 15-PGDH gene was not detected in carcinomas, with only a negligible expression of the enzyme. Conclusion: Our results suggested that 15- PGDH has tumor suppressor activity in gastric carcinomas.
참고문헌 (22)
- Eberhart CE, "Eicosanoids and gastrointestinal tract", Gastroenterology, 109, pp.285~301 (1995)
- Uefuji K, "Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer", Clin Cancer Res, 6, pp.135~138 (2000)
- DeWitt DL, "Prostaglandin endoperoxide synthase: regulation of enzyme expression", Biochim Biophys Acta, 1083, pp.121~134 (1991)
- Jones MK, "Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing", Nat Med, 5, pp.1418~1423 (1999)
- Tsujii M, "Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2", Cell, 83, pp.493~501 (1995)
- Tsujii M, "Cyclooxyenase-2 expression in human colon cancer cells increases metastatic potential", Proc Natl Acad Sci U S A, 94, pp.3336~3340 (1997)
- Tsujii M, "Cyclooxygenase regulates angiogenesis induced by colon cancer cells", Cell, 93, pp.705~716 (1998)
- Ristimäki A, "Expression of cyclooxygenase-2 in human gastric carcinoma", Cancer Res, 57, pp.1276~1280 (1997)
- Murata H, "Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma", Am J Gastroenterol, 94, pp.451~455 (1999)
- Lim HY, "Increased expression of cyclooxygenase-2 protein in human gastric carcinoma", Clin Cancer Res, 6, pp.519~525 (2000)
- Jang TJ, "Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis", Virchows Arch, 445, pp.564~571 (2004)
- Tai HH, "Prostaglandin catabolizing enzymes", Prostaglandins Other Lipid Mediat, 68-69, pp.483~493 (2002)
- Yan M, "15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-bata-induced suppressor of human gastrointestinal cancers", Proc Natl Acad Sci U S A, 101, pp.17468~17473 (2004)
- Backlund MG, "15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer", J Biol Chem, 280, pp.3217~3223 (2005)
- Ding Y, "NAD+- linked 15-hydroxyprostaglandin dehydrogenase (15- PGDH) behaves as a tumor suppressor in lung cancer", Carcinogenesis, 26, pp.65~72 (2005)
- Myung SJ, "15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis", Proc Natl Acad Sci U S A, 103, pp.12098~12102 (2006)
- Wolf I, "15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer", Cancer Res, 66, pp.7818~7823 (2006)
- Yoo NJ, "Expression of 15-hydroxyprostaglandin dehydrogenase, a COX-2 antagonist and tumour suppressor, is not altered in gastric carcinomas", Pathology, 39, pp.174~175 (2007)
- Herman JG, "Methylation-specific PCR: a novel PCR assay for methylation status of CpG island", Proc Natl Acad SciU S A, 93, pp.9821~9826 (1996)
- Lodygin D, "Functional epigenomics identifies genes frequently silenced in prostate cancer", Cancer Res, 65, pp.4218~4227 (2005)
- Yang L, "Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer", Cancer Res, 67, pp.5587~5593 (2007)
- Mann JR, "Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression", Cancer Res, 66, pp.6649~6656 (2006)